Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

Multiple costimulatory molecules involved in T cell–B cell interaction have been implicated in cancer prognosis. The role of tumour-infiltrating B cells (TIBs), however, remains controversial with ...

Early-onset CRC (EO-CRC) was associated with Flavonifractor plautii and increased bile acid, tryptophan, and choline ...

ROS activated the p53 signaling pathway and promoted the nuclear translocation ... Hdy-7 showed comparable cytotoxicity against five cancer cell lines, including Taxol resistant A549 Taxol cells.

1Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania. 2The Melanoma and Skin Cancer Center, The Pennsylvania State University College of Medicine, ...

Mol Cancer Ther (2025) 24 (4): 497–510 ... The trend of MDM2 degradation observed with KT-253 treatments corresponds to the activation of the p53 pathway, as evidenced by an upregulation of proteomic ...

suggesting collaboration between MCL-1 and P53 in maintaining a balance between cell survival and death in hair follicles. The mice model experiments also revealed that the ERBB signaling pathway ...

Detailed price information for Acrivon Therapeutics Inc (ACRV-Q) from The Globe and Mail including charting and trades.

Department of Ultrasound Imaging, Renmin Hospital of Wuhan University, Wuhan 430060, P. R. China ...